Daily Briefing

The omicron surge is hitting even highly vaccinated states. (But there's a silver lining.)


The omicron variant is more contagious and more vaccine-invasive than previous variants of Covid-19. When omicron began to surge in the United States, we wondered whether it would have a similar trajectory to the delta surge. There have been some key differences—including both bad and good news. We dug into the data to analyze the impact that vaccination rates will have on surges in hospitalization.

Access our new omicron surge toolkit 

Higher vaccination rates don't protect states from an omicron surge

The bad news first: It doesn't look like a higher vaccination rate offers ample protection against an omicron surge.

Nearly every state has experienced a lasting Covid-19 surge since December 2021, regardless of vaccination rate. (It's a good time to live in Alaska.) Furthermore, higher vaccination rates haven't brought down the number of days in surge, with an average surge time hovering around 20 days.  

Three factors explain the difference. Omicron is more contagious than previous variants of the virus, is more able to avoid immunity, and arrived in winter. The booster vaccine should offer improved immunity and protection against hospitalization, but rates are likely too low to meaningfully inflect hospitalizations at this point, ranging between 10% and 39% across states according to our analysis of CDC data.

But higher vaccination rates shorten intense surges

The good news: States with higher vaccination rates have experienced fewer days in intense surges.

This is true when Covid-19 patients occupy more than 20% of hospital beds in the state. So far, states with vaccination rates above 60% that experience an intense surge have spent an average nine days at that level. States with vaccination rates below 60% spent an average of 16 days.

That aligns with early evidence that suggests that a two-dose vaccine course offers meaningful protection against hospitalization.

Even in states with lower vaccination rates, there's hope that the omicron wave will be shorter than delta, though still more intense than in states with higher vaccination rates. By January 9, no state had gone more than nine days with more than 30% of hospital beds occupied by patients with Covid-19. During the delta wave, Florida and Georgia both spent 25 days at that peak intensity.

Looking at hospitalization rates alone may overstate the severity of the omicron wave. With a more contagious but milder infection, more patients are testing positive with the virus even if they aren't hospitalized because of the virus. Furthermore, patients hospitalized for Covid-19 caused by the omicron variant show lower length of stay, which might mitigate the impact of a higher hospitalization rate.

Staffing shortages and continued delta waves exacerbate the omicron surge

But with a clinical workforce plagued by burnout and stretched to the limit, even a “smaller” surge in hospitalizations places an outsized burden on the health care system. That’s especially true now; staff shortages have led to closures in non-hospital settings, pushing more patients to seek care at hospitals. At the same time, staff shortages leave nursing homes at capacity, leading to discharge delays that keep patients in the hospital for longer and constrain capacity.

Furthermore, the delta variant is still prevalent in parts of the country. As a result, some states might see more intense surges that mix both the higher numbers of patients with the omicron variant and the higher likelihood of hospitalization for patients with the delta variant. That mix could also extend the duration of the surge, with the omicron variant driving up case numbers as the delta variant fades in prevalence.

What this means for you

Based on this early analysis, we would speculate that states with vaccination rates above 60% should expect elevated hospitalizations for Covid-19 for the duration of the wave, but intense surges with over 20% of hospital beds occupied by patients with Covid-19 for about two weeks.

For states with vaccination rates under 60%, those intense surges are likely to last longer.

Across the country, staffing shortages are likely to make intense surges more difficult to manage than they were during the delta wave.

    Update on January 25: We returned to this analysis with two additional weeks of data and found that our main insight—that states with higher vaccination rates saw shorter intense surges—has changed. The new analysis shows them almost at parity: 17 days on average for states with lower rates, 19 days on average for states with higher rates.

    We think that’s probably a matter of timing. States with higher vaccination rates were more likely to be hit earlier, and therefore have experienced more days in surge in an ongoing wave. We expect that the average will be even closer as later-hit states, which also often have lower vaccination rates, reach their peak rate of beds occupied by patients with Covid-19.

    Definitions:

    • Surge: We describe any state with 10% of hospital beds occupied by patients with Covid-19 on any single as experiencing a surge. That's based on a median 3% rate on June 20, 2021, which was a low point between waves.
    • Intensity: We defined different levels of "intensity" for surges. More than 10% of beds in a state occupied by patients with Covid-19 on any single day constitutes a surge. The more intense surges are defined at over 20% and 30% of beds occupied by patients with Covid-19. 
    • Duration: We defined duration by the number of days a state qualified for surge. We did the same analysis for the number of days a state spent at over 20% and 30% of beds occupied by patients with Covid-19.

    Learn more: Check out our new omicron surge toolkit

    We've collected our best resources and insights for creating capacity, supporting staff, communicating with patients, and more. This page will be a consistent work in progress as we compile the newest and most helpful resources. Check out all the resources, including:


    SPONSORED BY

    INTENDED AUDIENCE

    AFTER YOU READ THIS

    AUTHORS

    TOPICS

    MORE FROM TODAY'S DAILY BRIEFING

    Don't miss out on the latest Advisory Board insights

    Create your free account to access 2 resources each month, including the latest research and webinars.

    Want access without creating an account?

       

    You have 2 free members-only resources remaining this month remaining this month.

    1 free members-only resources remaining this month

    1 free members-only resources remaining this month

    You've reached your limit of free monthly insights

    Become a member to access all of Advisory Board's resources, events, and experts

    Never miss out on the latest innovative health care content tailored to you.

    Benefits include:

    Unlimited access to research and resources
    Member-only access to events and trainings
    Expert-led consultation and facilitation
    The latest content delivered to your inbox

    You've reached your limit of free monthly insights

    Become a member to access all of Advisory Board's resources, events, and experts

    Never miss out on the latest innovative health care content tailored to you.

    Benefits include:

    Unlimited access to research and resources
    Member-only access to events and trainings
    Expert-led consultation and facilitation
    The latest content delivered to your inbox
    AB
    Thank you! Your updates have been made successfully.
    Oh no! There was a problem with your request.
    Error in form submission. Please try again.